Stay updated on AK002 for Antihistamine-Resistant Chronic Urticaria Clinical Trial
Sign up to get notified when there's something new on the AK002 for Antihistamine-Resistant Chronic Urticaria Clinical Trial page.

Latest updates to the AK002 for Antihistamine-Resistant Chronic Urticaria Clinical Trial page
- Check6 days agoChange DetectedA banner announces NIH website updates and says federal agencies are transitioning from the term “Artificial Intelligence” to “Super Intelligence.”SummaryDifference1%

- Check13 days agoChange DetectedThe footer site revision changed from v3.7.1 to v3.7.2 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check20 days agoChange DetectedThe site footer revision label changed from v3.7.0 to v3.7.1 while the study page remains unavailable behind a 403 Forbidden error.SummaryDifference0.2%

- Check41 days agoChange DetectedThe detailed study record content was deleted and replaced with a 403 Forbidden page, leaving only a basic header and navigation; the page now shows a restricted access state.SummaryDifference17%

- Check62 days agoChange DetectedThe page footer revision was updated from v3.6.5 to v3.6.6, signaling a new release of the page template. This update does not change study information or user-facing functionality.SummaryDifference0.1%

- Check83 days agoChange DetectedThe page now displays Revision: v3.6.5, indicating a backend/template update to the study record; no study content appears to be altered.SummaryDifference16%

Stay in the know with updates to AK002 for Antihistamine-Resistant Chronic Urticaria Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AK002 for Antihistamine-Resistant Chronic Urticaria Clinical Trial page.